Recurrence and mortality following severe cutaneous adverse reactions

No abstract available.

View Source

Information

Citation

Finkelstein Y, Macdonald EM, Li P, Hutson JR, Juurlink DN. JAMA. 2014; 311(21):2231–2. Epub 2014 Jun 4.

View Source

Contributing ICES Scientists

Discover More

Journal Article

27/07/2026

Pharmacist-led services for skin conditions and related physician visits in Ontario

Iskandar RJ, Ghahramani D, Jaakkimainen L, Nakhla N, Tadrous M, Drucker AM. J Cutan Med Surg. 2026; Jul 27 [Epub ahead of print].

Journal Article

15/11/2025

Systemic therapies for psoriatic disease and serious adverse events in older adults: a population-based cohort study

Drucker AM, Sutradhar R, Ling V, Eder L, Gomes T, Fralick M, Iskandar RJ, Li P, MacDougall S, Manolson M, Rochon PA, Tadrous M. J Invest Dermatol. 2025; S0022-202X(25)03528-6. Epub 2025 Nov 15.

Journal Article

02/04/2025

Characteristics of patients seeking skin-related minor ailment pharmacy services in Ontario, Canada: a population-based cross-sectional study

Iskandar RJ, Tadrous M, Nguyen P, Dolovich L, Green M, Frymire E, Drucker AM. Br J Dermatol. 2025; Apr 2 [Epub ahead of print].

See All

Recurrence and mortality following severe cutaneous adverse reactions

Information

Citation

Contributing ICES Scientists

Research Programs

Associated Topics

Associated Sites

Discover More

Pharmacist-led services for skin conditions and related physician visits in Ontario

Systemic therapies for psoriatic disease and serious adverse events in older adults: a population-based cohort study

Characteristics of patients seeking skin-related minor ailment pharmacy services in Ontario, Canada: a population-based cross-sectional study